Imatinib stimulates prostaglandin E2 and attenuates cytokine release via EP4 receptor activation - 07/02/19

| This research was supported by the Austrian Science Fund FWF (grant no. P22521-B18 to A.H.; grant nos. P30144-B26 and KLI521-B31 to R.S.; grant no. P22976-B18 to G.M.; and grant no. P26185-B19 to R.S.), the Jubiläumsfonds of the Austrian National Bank (grant no. 14263 to A.H.), and the LOEWE program from the state of Hesse (Translational Medicine and Pharmacology, TMP, to D.T.). T.B. was funded by the PhD Program DK-MOLIN (FWF – W1241). T.B. is a recipient of a DOC Fellowship of the Austrian Academy of Science and the Start Funding Program of the Medical University of Graz. |
|
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
Vol 143 - N° 2
P. 794 - février 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
